Stephen P. Christiansen

Stephen P. Christiansen


Research Focus & Metrics

Academic Career Length

38Years (1989-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 August 2008 in Science
Verified
Journal Article
Closed access
PDF file
NMNoriko Miyake
Noriko Miyake
JCJohn Chilton
John Chilton
MPMaria Psatha
Maria Psatha
LCLong Cheng
Long Cheng
CACaroline Andrews
Caroline Andrews
EEElizabeth C Engle
Elizabeth C Engle
Duane's retraction syndrome (DRS) is a complex congenital eye movement disorder caused by aberrant innervation of the extraocular muscles by axons of brainstem motor neurons. Studying families with a variant form of the disorder (DURS2-DRS), we have identified causative heterozygous missense mutations in CHN1 , a gene on chromosome 2q31 that encodes α2-chimaerin, a Rac guanosine triphosphatase–activating protein (RacGAP) signaling protein previously implicated in the pathfinding of corticospinal axons in mice. We found that these are gain-of-function mutations that increase α2-chimaerin RacGAP activity in vitro. Several of the mutations appeared to enhance α2-chimaerin translocation to the cell membrane or enhance its ability to self-associate. Expression of mutant α2-chimaerin constructs in chick embryos resulted in failure of oculomotor axons to innervate their target extraocular muscles. We conclude that α2-chimaerin has a critical developmental function in ocular motor axon pathfinding.

1 November 2003 in Archives of Ophthalmology (1950)
Verified
Journal Article
Closed access
PDF file
JHJonathan M Holmes
Jonathan M Holmes
RBRoy W Beck
Roy W Beck
RKRaymond T Kraker
Raymond T Kraker
SCStephen R Cole
Stephen R Cole
MRMichael X Repka
Michael X Repka
PGPediatric Eye Disease Investigator Group
Pediatric Eye Disease Investigator Group
Research from JAMA Ophthalmology — Impact of Patching and Atropine Treatment on the Child and Family in the Amblyopia Treatment Study

1 February 1995 in American Journal of Ophthalmology
Verified
Journal Article
Closed access
SCStephen P. Christiansen
Stephen P. Christiansen
JBJ. David Bradford
J. David Bradford

1 November 2005 in Investigative Ophthalmology & Visual Science
Verified
Journal Article
Closed access
PDF file
IUIrma Ugalde
Irma Ugalde
SCStephen P. Christiansen
Stephen P. Christiansen
LMLinda K Mcloon
Linda K Mcloon
Purpose. Botulinum toxin A (Botox) is commonly used for strabismus treatment. Although other muscles atrophy after intramuscular injection with Botox, extraocular muscles (EOMs) do not. A continuous process of myonuclear addition in normal uninjured adult myofibers in rabbit EOMs was studied. In this study, the effect of Botox-induced muscle paralysis on myofiber remodeling in adult EOMs was examined. methods. The superior rectus muscles of adult rabbits were each injected with 5 units of Botox. The contralateral muscle received injections of saline only. Bromodeoxyuridine (BrdU) was administered for various periods after Botox treatment, followed by various BrdU-free periods. Myonuclear addition, the number of BrdU-positive satellite cells, and the number of MyoD-positive satellite cells were quantified, as were alterations in expression of immature myosins. results. Intramuscular injection of Botox resulted in a significant increase in both the number of BrdU-positive myonuclei and satellite cells. MyoD expression in both satellite cells and myonuclei was significantly increased after Botox injection in EOMs. In Botox-treated EOMs, an increased number of myofibers positive for the neonatal myosin heavy chain (MyHC) isoform was detected in the orbital layer. conclusions. Botox-induced EOM paralysis resulted in a significant short-term increase in satellite cell activation and myonuclear addition in single myofibers in adult rabbit EOMs compared with control muscles. The appearance of MyoD-positive myonuclei suggests that protein synthesis becomes upregulated after Botox injection, and this, in turn, may help explain the minimal effects on myofiber size in EOMs after Botox injection. Understanding the effect of Botox on satellite cell activation and myonuclear addition in existing myofibers may suggest new ways to maximize the clinical effectiveness of Botox in patients with strabismus.

1 December 2003 in Journal of American Association for Pediatric Ophthalmology and Strabismus
Verified
Journal Article
Closed access
SLScott R Lambert
Scott R Lambert
MLMichael Lynn
Michael Lynn
CDCarolyn Drews-Botsch
Carolyn Drews-Botsch
LDLindreth DuBois
Lindreth DuBois
MWM.EDward Wilson
M.EDward Wilson
SDSean P Donahue
Sean P Donahue

1 June 2006 in Investigative Ophthalmology & Visual Science
Verified
Journal Article
Open access
PDF file
BABrian C. Anderson
Brian C. Anderson
SCStephen P. Christiansen
Stephen P. Christiansen
SGSteven Grandt
Steven Grandt
RGRobert W. Grange
Robert W. Grange
LMLinda K Mcloon
Linda K Mcloon
Purpose. Previous work has demonstrated the effectiveness of insulin-like growth factor (IGF)-II in increasing force generation in extraocular muscle (EOM). Studies in the literature have suggested that IGF-I would be even more effective than IGF-II. This study was performed to assess the effects on muscle mass and force generation of IGF-I injection in adult rabbit superior rectus muscle. methods. Adult rabbits received a single injection of IGF-I at one of several doses into one superior rectus muscle. One week after treatment, the rabbits were euthanatized, and the superior rectus muscle from each orbit was removed. Force generation was measured using an in vitro apparatus, and injected muscles were compared with the contralateral control. A second group of animals were injected similarly, and the muscles were examined at 1 week for changes in cross-sectional area of individual myofibers. results. EOMs demonstrate significant numbers of cells expressing the IGF receptor. After the EOMs were injected with IGF-I, there were significant increases both in muscle force generation and cross-sectional area at all doses tested in this study. Doses of 10 and 25 μg IGF-I were most effective. conclusions. Direct muscular injection of IGF-I effectively increases EOM force generation without the potential biomechanical hazards of surgery such as permanently altered muscle length or insertional position on the globe.